The polymeric biomaterials market size has grown rapidly in recent years. It will grow from $50.97 billion in 2023 to $59.69 billion in 2024 at a compound annual growth rate (CAGR) of 17.1%. The growth during the historic period can be attributed to several factors, including increased demand for medical implants, improved biocompatibility of materials, the emergence of tissue engineering, a rise in orthopedic surgeries, and the development of advanced drug delivery systems.
The polymeric biomaterials market size is expected to see rapid growth in the next few years. It will grow to $113.07 billion in 2028 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to several factors, including the advancement of regenerative medicine and personalized medicine, growing environmental concerns, the adoption of 3D printing technology, advancements in chronic disease management, and the increasing popularity of minimally invasive surgery techniques. Major trends expected during this period include progress in polymer chemistry, innovations in biomedical engineering, regulatory approvals for new technologies, integration of advanced technologies, and increased academic research in the field.
The rise in chronic diseases prevalence is expected to drive the growth of the polymeric biomaterials market in the foreseeable future. Chronic diseases, characterized by long-lasting conditions that progress slowly and persist over time, are increasingly prevalent due to factors such as aging populations, lifestyle choices, economic burdens, healthcare needs, and public health challenges. Polymeric biomaterials play a crucial role in treating chronic diseases by offering innovative solutions that enhance medical treatments' effectiveness and contribute to individuals' overall quality of life. These materials are also integral to developing various medical devices and implants, such as stents, catheters, and joint replacements, essential for managing chronic conditions requiring surgical intervention. For example, the World Health Organization (WHO) reported that chronic diseases account for 74% of global deaths, including millions from cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes annually. This underscores how the growing prevalence of chronic diseases fuels the polymeric biomaterials market's expansion.
Leading companies in the polymeric biomaterials market are focusing on developing innovative solutions, such as 3D printable biomaterials, to maintain their competitive edge. 3D printable biomaterials are a class of materials compatible with three-dimensional (3D) printing technologies for medical applications, enabling the creation of structures and devices. For instance, in March 2022, Evonik Industries AG launched VESTAKEEP iC4800 3DF, a novel osteoconductive PEEK filament facilitating bone and implant fusion. This high-performance polymeric biomaterial enhances bone growth and is ideal for 3D-printed medical implants due to its biocompatibility and osteoconductive properties. The VESTAKEEP iC4800 3DF filament enables the creation of patient-specific implants, improving fusion, accelerating healing, and customizing implant designs, thus expanding Evonik's portfolio of 3D printable biomaterials for medical applications.
In May 2022, Huafon Group Co. Ltd. acquired the Biomaterials business from DuPont de Nemours Inc. for approximately $240 million, enhancing its specialized materials portfolio for medical and healthcare applications. This strategic move positions Huafon Group to capitalize on the growing demand for polymeric biomaterials across various sectors, including healthcare and biomedical research. DuPont de Nemours Inc. is renowned for its production of polymeric biomaterials and bio-based material solutions.
Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Huafon Group, W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.
North America was the largest region in the polymeric biomaterials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the polymeric biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Polymeric biomaterials are engineered materials designed to interact with biological systems for therapeutic or diagnostic purposes. These materials have been developed to elicit specific biological responses and play a crucial role in tissue engineering, offering a wide range of functionalities including drug delivery, micropatterning, and microfluidics.
The primary types of polymeric biomaterial products include polylactic acid, polyglycolic acid, polyurethanes, polytetrafluoroethylene, polyaryletheretherketone, polydioxanone, and others. Polylactic acid (PLA) is a biodegradable thermoplastic polyester derived from renewable resources such as corn starch, cassava roots, or sugarcane. These materials find applications in various fields including cardiovascular, dental, orthopedic, plastic surgery, neurology, among others, and are utilized by a variety of end-users including hospitals, clinics, and others.
The polymeric biomaterials market research report is one of a series of new reports that provides polymeric biomaterials market statistics, including polymeric biomaterials industry global market size, regional shares, competitors with a polymeric biomaterials market share, detailed polymeric biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the polymeric biomaterials industry. This polymeric biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The polymeric biomaterials market consists of sales of biomedical sensors and monitors, dental products, wound care products, medical devices and implants, and dressings and bandages. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The polymeric biomaterials market size is expected to see rapid growth in the next few years. It will grow to $113.07 billion in 2028 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to several factors, including the advancement of regenerative medicine and personalized medicine, growing environmental concerns, the adoption of 3D printing technology, advancements in chronic disease management, and the increasing popularity of minimally invasive surgery techniques. Major trends expected during this period include progress in polymer chemistry, innovations in biomedical engineering, regulatory approvals for new technologies, integration of advanced technologies, and increased academic research in the field.
The rise in chronic diseases prevalence is expected to drive the growth of the polymeric biomaterials market in the foreseeable future. Chronic diseases, characterized by long-lasting conditions that progress slowly and persist over time, are increasingly prevalent due to factors such as aging populations, lifestyle choices, economic burdens, healthcare needs, and public health challenges. Polymeric biomaterials play a crucial role in treating chronic diseases by offering innovative solutions that enhance medical treatments' effectiveness and contribute to individuals' overall quality of life. These materials are also integral to developing various medical devices and implants, such as stents, catheters, and joint replacements, essential for managing chronic conditions requiring surgical intervention. For example, the World Health Organization (WHO) reported that chronic diseases account for 74% of global deaths, including millions from cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes annually. This underscores how the growing prevalence of chronic diseases fuels the polymeric biomaterials market's expansion.
Leading companies in the polymeric biomaterials market are focusing on developing innovative solutions, such as 3D printable biomaterials, to maintain their competitive edge. 3D printable biomaterials are a class of materials compatible with three-dimensional (3D) printing technologies for medical applications, enabling the creation of structures and devices. For instance, in March 2022, Evonik Industries AG launched VESTAKEEP iC4800 3DF, a novel osteoconductive PEEK filament facilitating bone and implant fusion. This high-performance polymeric biomaterial enhances bone growth and is ideal for 3D-printed medical implants due to its biocompatibility and osteoconductive properties. The VESTAKEEP iC4800 3DF filament enables the creation of patient-specific implants, improving fusion, accelerating healing, and customizing implant designs, thus expanding Evonik's portfolio of 3D printable biomaterials for medical applications.
In May 2022, Huafon Group Co. Ltd. acquired the Biomaterials business from DuPont de Nemours Inc. for approximately $240 million, enhancing its specialized materials portfolio for medical and healthcare applications. This strategic move positions Huafon Group to capitalize on the growing demand for polymeric biomaterials across various sectors, including healthcare and biomedical research. DuPont de Nemours Inc. is renowned for its production of polymeric biomaterials and bio-based material solutions.
Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Huafon Group, W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.
North America was the largest region in the polymeric biomaterials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the polymeric biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Polymeric biomaterials are engineered materials designed to interact with biological systems for therapeutic or diagnostic purposes. These materials have been developed to elicit specific biological responses and play a crucial role in tissue engineering, offering a wide range of functionalities including drug delivery, micropatterning, and microfluidics.
The primary types of polymeric biomaterial products include polylactic acid, polyglycolic acid, polyurethanes, polytetrafluoroethylene, polyaryletheretherketone, polydioxanone, and others. Polylactic acid (PLA) is a biodegradable thermoplastic polyester derived from renewable resources such as corn starch, cassava roots, or sugarcane. These materials find applications in various fields including cardiovascular, dental, orthopedic, plastic surgery, neurology, among others, and are utilized by a variety of end-users including hospitals, clinics, and others.
The polymeric biomaterials market research report is one of a series of new reports that provides polymeric biomaterials market statistics, including polymeric biomaterials industry global market size, regional shares, competitors with a polymeric biomaterials market share, detailed polymeric biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the polymeric biomaterials industry. This polymeric biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The polymeric biomaterials market consists of sales of biomedical sensors and monitors, dental products, wound care products, medical devices and implants, and dressings and bandages. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Polymeric Biomaterials Market Characteristics3. Polymeric Biomaterials Market Trends And Strategies32. Global Polymeric Biomaterials Market Competitive Benchmarking33. Global Polymeric Biomaterials Market Competitive Dashboard34. Key Mergers And Acquisitions In The Polymeric Biomaterials Market
4. Polymeric Biomaterials Market - Macro Economic Scenario
5. Global Polymeric Biomaterials Market Size and Growth
6. Polymeric Biomaterials Market Segmentation
7. Polymeric Biomaterials Market Regional And Country Analysis
8. Asia-Pacific Polymeric Biomaterials Market
9. China Polymeric Biomaterials Market
10. India Polymeric Biomaterials Market
11. Japan Polymeric Biomaterials Market
12. Australia Polymeric Biomaterials Market
13. Indonesia Polymeric Biomaterials Market
14. South Korea Polymeric Biomaterials Market
15. Western Europe Polymeric Biomaterials Market
16. UK Polymeric Biomaterials Market
17. Germany Polymeric Biomaterials Market
18. France Polymeric Biomaterials Market
19. Italy Polymeric Biomaterials Market
20. Spain Polymeric Biomaterials Market
21. Eastern Europe Polymeric Biomaterials Market
22. Russia Polymeric Biomaterials Market
23. North America Polymeric Biomaterials Market
24. USA Polymeric Biomaterials Market
25. Canada Polymeric Biomaterials Market
26. South America Polymeric Biomaterials Market
27. Brazil Polymeric Biomaterials Market
28. Middle East Polymeric Biomaterials Market
29. Africa Polymeric Biomaterials Market
30. Polymeric Biomaterials Market Competitive Landscape And Company Profiles
31. Polymeric Biomaterials Market Other Major And Innovative Companies
35. Polymeric Biomaterials Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Polymeric Biomaterials Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on polymeric biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for polymeric biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymeric biomaterials market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Polylactic Acid; Polyglycolic Acid; Polyurethanes; Polytetrafluoroethylene; Polyaryletherketone; Polydioxanone; Other Products2) By Application: Cardiovascular; Dental; Orthopedic; Plastic Surgery; Neurology; Other Applications
3) By End-User: Hospitals; Clinics; Other End-users
Key Companies Mentioned: BASF SE; 3M Company; Medtronic plc; Toray Industries Inc.; Evonik Industries AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BASF SE
- 3M Company
- Medtronic plc
- Toray Industries Inc.
- Evonik Industries AG
- Covestro AG
- Stryker Corporation
- Solvay SA
- DuPont Biomaterials
- Arkema Group
- Mitsubishi Chemical Holdings Inc.
- Celanese Corporation
- Royal DSM
- TEIJIN Limited
- Zimmer Biomet Holdings Inc.
- Dentsply Sirona Inc.
- Huafon Group
- W. L. Gore & Associates Inc.
- Corbion NV
- Integra LifeSciences Holdings Corporation
- Victrex plc
- Collagen Matrix
- Berkeley Advanced Biomaterials
- Bezwada Biomedical LLC
- Covation Biomaterials
- Starch Medical Inc.
Methodology
LOADING...